ArticleAnnals of surgical oncology2026
Immediate Second Look After Cytoreduction for Colorectal or Ovarian Carcinomatosis: An Invisible Gorilla Effect?
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundComplete cytoreductive surgery (CRS) is critical for cure in peritoneal metastases (PM) from colorectal cancer (CRC) or ovarian cancer. This study prospectively evaluated whether an immediate second look improved detection of residual malignant nodules after CRS was deemed complete.
methodsEligible patients had histologically confirmed PM from CRC or ovarian cancer and were undergoing CC0 CRS performed by a senior surgeon. Once the procedure was complete, a second senior, blinded surgeon immediately conducted a full peritoneal re-exploration. Additional suspicious nodules were resected and sent for pathology analysis.
resultsFrom November 2021 to October 2024, a total of 172 patients underwent CC0 CRS for PM from CRC or ovarian cancer at one comprehensive cancer center, and 59 patients were enrolled. Most exclusions were for organizational reasons. PM originated from CRC in 35 patient and ovarian cancer in 24. The median surgical Peritoneal Cancer Index was 6 (interquartile range 4-14.5). The second look resulted in resection of additional suspected nodules in 88.1% of patients, and malignancy was pathologically confirmed in 47.4%. The proportion of patients in whom malignant nodules were missed during the initial inspection ranged from 25 to 80%. Surgeons demonstrated a high level of attention on cognitive tests conducted before and after the CRS. Errors and omissions remained rare but were consistently observed throughout the test.
conclusionNearly half of patients had residual malignant disease after CRS initially judged as complete. These findings underscore perceptual limitations in intraoperative detection and support the utility of intraoperative systematic second look to enhance surgical thoroughness.η.
Indexed as
Identifiers
41865210What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.